Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

New Nanomaterial Promises Enhanced Detection and Treatment of Breast Cancer

By BiotechDaily International staff writers
Posted on 07 Jan 2014
Image: Muonium [an exotic atom made up of an antimuon and an electron] trapped inside a buckyball. Muons provide a complementary probe to neutrons, particularly in the areas of magnetism, superconductivity, and charge transport (Photo courtesy of ISIS).
Image: Muonium [an exotic atom made up of an antimuon and an electron] trapped inside a buckyball. Muons provide a complementary probe to neutrons, particularly in the areas of magnetism, superconductivity, and charge transport (Photo courtesy of ISIS).
A collaboration of scientists from the United Kingdom, Denmark, Brazil, and Germany are devising new detection and treatment technology for breast cancer patients.

The study’s findings were published December 2013 in the Journal of Alloys and Compounds. Current diagnostic methods such as mammograms can only detect between 65% and 95% of tumors, and developing better ways of detection is of prime urgency. If not detected and treated early enough, breast cancer can spread to other areas of the body, increasing the probability that the disease will become lethal.

The team of scientists has been using the Polaris instrument at the ISIS pulsed neutron and muon source at the Rutherford Appleton Laboratory (Harwell Oxford, UK) to develop a new bio-nanocomposite that they hope will eventually lead to earlier detection, and more successful treatment, of breast cancer. The new substance exploits the fact that cancer cells attract a molecule called hydroxyapatite, which is a component of bones. The researchers are developing magnetic nanoparticles coated with a biocompatible polymer that includes hydroxyapatite nanocrystals. When administered into the body, these nanoparticles should travel right to cancer cells, and once they do, they make it much easier to detect the tumor on an MRI scan.

Not only do the nanoparticles help to identify tumors, but they may also help to block the metastasis to other areas of the body, as hydroxyapatite is known to suppress that facet of tumor activity.

The next phase of study is to incorporate antitumor agents into the nanoparticles. The magnetic nature of the nanoparticles means that they can be directed to the site of the tumor by using magnets outside of the body. If antitumor drugs can be added to the nanoparticles, then they can be used to deliver the treatment directly to the tumor, optimizing the effectiveness of the treatment and reducing the risk of harmful side effects--imagine a fleet of tiny drones, delivering anticancer weapons right where they are needed.

This research is at a very early stage, and far more study is required, according to the scientists, before it can be developed into a treatment option.

ISIS generates beams of neutrons and muons that allow scientists to study materials at the atomic level using a suite of instruments, frequently described as super-microscopes. It supports a national and international community of more than 2,000 scientists who use neutrons and muons for research in physics, chemistry, materials science, geology, engineering, and biology.

Related Links:

ISIS



Channels

Genomics/Proteomics

view channel
Image: Transmission electron micrograph of norovirus particles in feces (Photo courtesy of Wikimedia Commons).

Norovirus Interacts with Gut Bacteria to Establish a Persistent Infection That Can Be Blocked by Interferon Lambda

A team of molecular microbiologists and virologists has found that norovirus requires an intimate interaction with certain gut bacteria to establish a persistent infection, and that the infective process... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Therapeutics

view channel
Image: Cancer cells infected with tumor-targeted oncolytic virus (red). Green indicates alpha-tubulin, a cell skeleton protein. Blue is DNA in the cancer cell nuclei (Photo courtesy of Dr. Rathi Gangeswaran, Bart’s Cancer Institute).

Innovative “Viro-Immunotherapy” Designed to Kill Breast Cancer Cells

A leading scientist has devised a new treatment that employs viruses to kill breast cancer cells. The research could lead to a promising “viro-immunotherapy” for patients with triple-negative breast cancer,... Read more

Lab Technologies

view channel
Image: MIT researchers have designed a microfluidic device that allows them to precisely trap pairs of cells (one red, one green) and observe how they interact over time (Photo courtesy of Burak Dura, MIT).

New Device Designed to See Communication between Immune Cells

The immune system is a complicated network of many different cells working together to defend against invaders. Effectively combating an infection depends on the interactions between these cells.... Read more

Business

view channel

Program Designed to Provide High-Performance Computing Cluster Systems for Bioinformatics Research

Dedicated Computing (Waukesha, WI, USA), a global technology company, reported that it will be participating in the Intel Cluster Ready program to deliver integrated high-performance computing cluster solutions to the life sciences market. Powered by Intel Xeon processors, Dedicated Computing is providing a range of... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.